Canadian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients

  • 8/5/21 10:50 AM
  • CCMB Communications & Public Affairs

Congratulations to Dr. Ryan Zarychanski and the research teams locally and globally for their publication in NEJM.
"Our findings will translate into lives saved and reduced burden of critically ill patients on health systems around the world.", says Dr. Zarychanski.
Thank you to CCMF who partnered in the initial funding to provide Manitoba the opportunity to lead this trial for the world.

Click here to read the UM Today article.